Op-Eds

Publish Date
‘March-in’ rights: Why Biden’s changes contradict the point of the Bayh-Dole Act
WIPR
Andrei Iancu and David Kappos
When inventors get an AI assist, who gets the patent?
Context
Andrei Iancu and Rama Elluru
The Biden administration should not support a WTO petition to strip IP protections from Covid-19 treatments
STAT
David Kappos and Andrei Iancu
Biden’s Bayh-Dole Act proposal misuses ‘march-in rights’
Detroit News
Judge Paul Michel ret. and Judge Kathleen O 'Malley ret.
Europe Stands at a Crossroads on Technology Policy
Euractiv
Andrei Iancu, David Kappos, Judge Kathleen O 'Malley, and Judge Paul Michel
President Biden’s domestic technology seizure plan
The Hill
Andrei Iancu and David Kappos
White House’s Drug Patent Plan Undercuts Research and Innovation
Bloomberg Law
Paul Michel and Kathleen O 'Malley
Blame Washington for Drug Shortages
RealClearHealth
Merrill Matthews
Waiving COVID-19 IP Protections Would Harm US Industry
Law360
Judge Paul Michel
Innovators Need Patent Reform Now
InsideSources
Frank Cullen
Noncompete legislation will hamper New York’s high tech industry
The Buffalo News
Andrei Iancu and David Kappos
A Wake-up Call for American Innovation
RealClearHealth
Andrei Iancu
Scroll to Top